论文部分内容阅读
目的探析胺碘酮治疗急诊冠心病快速心律失常的临床效果。方法 70例急诊冠心病快速心律失常患者,按治疗方法不同分为对照组和研究组,各35例。对照组患者行普罗帕酮治疗,研究组患者行胺碘酮治疗,比较两组治疗效果及心功能指标。结果研究组患者总有效率为82.86%,显著高于对照组的60.00%,差异具有统计学意义(P<0.05);研究组再梗死率低于对照组,心房颤动(房颤)转复率高于对照组,差异具有统计学意义(P<0.05)。研究组左心室射血分数(LVEF)、左心室舒张末期容积(LVEDV)、左心室收缩末期容积(LVESV)心功能指标优于对照组,差异具有统计学意义(P<0.05)。结论冠心病快速心律失常患者行胺碘酮治疗不仅能提高临床疗效,而且还能改善心功能,值得临床推广。
Objective To investigate the clinical effect of amiodarone in treating acute tachyarrhythmia of coronary heart disease. Methods Seventy patients with acute coronary heart disease with arrhythmia were divided into control group and study group according to different treatment methods, 35 cases in each group. Patients in the control group were treated with propafenone. Patients in the study group were treated with amiodarone. The therapeutic effect and cardiac function were compared between the two groups. Results The total effective rate of the study group was 82.86%, which was significantly higher than that of the control group (60.00%), the difference was statistically significant (P <0.05); the reinfarction rate was lower in the study group than in the control group; the rate of atrial fibrillation Higher than the control group, the difference was statistically significant (P <0.05). The left ventricular ejection fraction (LVEF), left ventricular end-diastolic volume (LVEDV) and left ventricular end-systolic volume (LVESV) in the study group were significantly higher than those in the control group (P <0.05). Conclusion Amiodarone in patients with coronary heart disease with tachyarrhythmia can not only improve the clinical curative effect, but also improve the cardiac function and deserve clinical promotion.